Variant Specific Periostin Neutralization for Diabetic Retinopathy
A new therapeutic mechanism to inhibit cytokine production from topical IL-17-producing cells by CD9…
Treatment of immunological diseases by a new mechanism to control the immune Th1/Th2 balance
-
This page is currently available only in Japanese.
New therapeutic targets and therapeutic agents for trauma-induced heterotopic ossification in FOP pa…
Cell Surface Antigen CD48 as A Novel Molecular Target for Antibody Therapy in Multiple Myeloma
Selective inhibition of Periostin variant (PN1) by monoclonal antibody
CHRNB2, a novel target for gastric cancer, potentially other tumors
Predicting therapeutic efficacy of combined immunotherapy such as atezolizumab/bevacizumab using CD1…